A method for screening a cysteine protease inhibitor of which cysteine protease inhibitory activity is enhanced in the presence of endogenous polyvalent metal ion, which comprises treating a cysteine protease with a test compound in the presence of the polyvalent metal ion, and a pharmaceutical composition for treating apoptosis-associated diseases, which contains as the active ingredient a cysteine protease inhibitor of which cysteine protease inhibitory activity is enhanced in the presence of endogenous polyvalent metal ion.
一种筛选半胱
氨酸蛋白酶抑制剂的方法,其半胱
氨酸
蛋白酶抑制活性在内源性多价
金属离子存在下得到增强,该方法包括在多价
金属离子存在下用测试化合物处理半胱
氨酸
蛋白酶,以及一种治疗细胞凋亡相关疾病的药物组合物,其活性成分含有半胱
氨酸蛋白酶抑制剂,其半胱
氨酸
蛋白酶抑制活性在内源性多价
金属离子存在下得到增强。